XML 50 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
SEGMENT INFORMATION (Tables)
 9 Months Ended
Jul. 31, 2016
Segment Reporting [Abstract]  
Segment Profitability and Segment Assets
The profitability of each of the segments is measured after excluding restructuring and asset impairment charges, investment gains and losses, interest income, interest expense, acquisition and integration costs, non-cash amortization and other items as noted in the reconciliations below.
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Three months ended July 31, 2016:
 

 
 

 
 

 
 

Total net revenue
$
504

 
$
180

 
$
360

 
$
1,044

Segment income from operations
$
96

 
$
34

 
$
82

 
$
212

Three months ended July 31, 2015:
 

 
 

 
 

 
 

Total net revenue
$
511

 
$
167

 
$
336

 
$
1,014

Segment income from operations
$
95

 
$
28

 
$
76

 
$
199

 
 
 
 
 
 
 
 
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Nine months ended July 31, 2016:
 

 
 

 
 

 
 

Total net revenue
$
1,525

 
$
516

 
$
1,050

 
$
3,091

Segment income from operations
$
304

 
$
76

 
$
232

 
$
612

Nine months ended July 31, 2015:
 

 
 

 
 

 
 

Total net revenue
$
1,531

 
$
484

 
$
988

 
$
3,003

Segment income from operations
$
277

 
$
54

 
$
213

 
$
544

The following table reflects segment assets under our management reporting system. Segment assets include allocations of corporate assets, including deferred tax assets, goodwill, net other intangibles and other assets. Unallocated assets primarily consist of cash, cash equivalents, the valuation allowance relating to deferred tax assets and other assets.  
 
Life Sciences and Applied Markets
 
Diagnostics and Genomics
 
Agilent CrossLab
 
Total
 
(in millions)
Assets:
 

 
 

 
 

 
 

As of July 31, 2016
$
1,676

 
$
1,988

 
$
1,057

 
$
4,721

As of October 31, 2015
$
1,539

 
$
2,027

 
$
1,008

 
$
4,574


 
Reconciliation of segment results to total enterprise results
The following table reconciles reportable segments’ income from operations to Agilent’s total enterprise income before taxes: 
 
Three Months Ended
 
Nine Months Ended
 
July 31,
 
July 31,
 
2016
 
2015
 
2016
 
2015
 
(in millions)
Total reportable segments’ income from operations
$
212

 
$
199

 
$
612

 
$
544

Acceleration of share-based compensation related to workforce reduction
—

 
—

 
—

 
(2
)
Asset impairments
(4
)
 
—

 
(4
)
 
—

Transformational initiatives
(11
)
 
(12
)
 
(32
)
 
(41
)
Amortization of intangibles
(37
)
 
(38
)
 
(120
)
 
(119
)
Acquisition and integration costs
(11
)
 
(4
)
 
(28
)
 
(6
)
Business exit and divestiture costs (primarily our NMR business)
(1
)
 
—

 
(7
)
 
(11
)
Pension curtailment gain
—

 
—

 
16

 
—

Other
(2
)
 
(1
)
 
(5
)
 
1

Interest income
3

 
2

 
8

 
6

Interest expense
(17
)
 
(17
)
 
(53
)
 
(50
)
Other income (expense), net
2

 
(1
)
 
6

 
15

Income from continuing operations before taxes, as reported
$
134

 
$
128

 
$
393

 
$
337